Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02195583 · ClinicalTrials.gov registry record · NA
The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ
A NA study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02195583 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 62 participants.
The verdict
NCT02195583, a NA study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study will evaluate the effect of experimental sodium fluoride-silica dentifrice formulations, with and without zinc, on remineralization of enamel in situ. Following the remineralization phase, the acid resistance of the new mineral formed will be assessed. Fluoride uptake during the remineralization phase will also be measured.
Interventions
- DRUG Sodium fluoride (1426 ppm)
- DRUG Sodium fluoride (1150 ppm)
- DRUG Sodium fluoride (250 ppm)
- DRUG Sodium fluoride (1426 ppm) + zinc base A
- DRUG Sodium fluoride (1426 ppm) + zinc base B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02195583
The ClinicalTrials.gov registry entry for NCT02195583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Sodium fluoride (1426 ppm) is the first listed.
NCT02195583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02195583 about?
NCT02195583 is a clinical study titled "The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ". This study will evaluate the effect of experimental sodium fluoride-silica dentifrice formulations, with and without zinc, on remineralization of enamel in situ. Following the remineralization phase, the acid resistance of the new mineral formed will be assessed. Fluoride uptake during the remineral...
What is the current status of trial NCT02195583?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02195583?
The interventions under investigation include: Sodium fluoride (1426 ppm) (DRUG), Sodium fluoride (1150 ppm) (DRUG), Sodium fluoride (250 ppm) (DRUG), Sodium fluoride (1426 ppm) + zinc base A (DRUG), Sodium fluoride (1426 ppm) + zinc base B (DRUG).
Who is sponsoring clinical trial NCT02195583?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.